Finland· FI-REL-REL41477
Amyvid
A florbetapir (18f) product containing florbetapir (18f), registered in Finland by Eli Lilly Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Florbetapir (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX05 (florbetapir (18f)), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Florbetapir (18f) · ATC V09AX05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Florbetapir (18F)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Finland (FI)
- ATC code
- V09AX05
- ATC class
- Florbetapir (18F)
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Florbetapir (18f) in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMYVIDEli Lilly Nederland B.V., Utrecht
- SpainAMYVID 1.900 MBq/ml solucion inyectableEli Lilly Nederland B.V.
- IrelandAmyvid 1,900 MBq/mL solution for injectionEli Lilly Nederland B.V.
- SwedenAmyvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- Japanフロルベタピル（１８Ｆ）ＰＤＲファーマ
- United StatesAmyvidEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amyvid
- Liechtenstein · Amyvid
- Norway · Amyvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffd66762-3f3b-4598-af49-8d51597776a5 GET /v1/drugs/ffd66762-3f3b-4598-af49-8d51597776a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "1900 MBq/ml",
"atc_label": "florbetapiiri(18F)",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/12/805/003-004",
"fimea_rel_id": "REL41477",
"authorised_at": "2013-01-14"
}See everything about florbetapir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.